Cited by 1,252Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms

Propagation of Tau Misfolding from the Outside to the Inside of a Cell

Open access
Frost, Bess, Jacks, Rachel L., Diamond, Marc I.·2009·Journal of Biological Chemistry

Abstract

Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m808759200

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change.

    “Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change (Colin et al. 2020, Frost et al. 2009).”

    From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Frost et al. 2009

    The Abstract and Discussion report that extracellular tau aggregates seed intracellular tau misfolding and that newly aggregated tau transfers between co-cultured cells. The Discussion says it remains uncertain whether transferred aggregates induce further aggregation in recipient cells; the study also does not demonstrate that toxicity spreads between cells. The claim presents those steps as an established mechanism. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Tau propagates pathology among neurons.

    “Several lines of evidence indicate tau propagates pathology among neurons.”

    From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009

    The Abstract reports Tau-induced misfolding and transfer of aggregated Tau between co-cultured cells. The Discussion says these findings are consistent with propagation among neurons, but explicitly says that this idea awaits testing in vivo. The paper therefore supports evidence for a possible mechanism, not a demonstrated spread of pathology among neurons. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner.

    “Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
  • Tau assemblies enter cells to trigger intracellular aggregation.

    “Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”

    From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009

  • Aggregation of tau impairs axons, leading to neurodegeneration.

    “The aggregation of tau impairs the axons, leading to neurodegeneration [23].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., and Ghetti, B. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7737-7741
  2. Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., and Kirschner, M. W. (1975) Proc. Natl. Acad. Sci. U. S. A. 72, 1858 -1862
  3. Greenberg, S. G., and Davies, P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5827-5831
  4. Friedhoff, P., von Bergen, M., Mandelkow, E. M., Davies, P., and Man- delkow, E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 15712-15717
  5. Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., and Raposo, G. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 9683-9688

Cited by

Sorted by citations

Authors
Frost, B., Jacks, R. L., & Diamond, M. I.
Affiliations
University of California, San Francisco (US)
Corresponding author
Diamond, Marc I.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2009-05
Volume
284
Issue
19
Pages
12845-12852
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1989208474
Cited by
1,252
References
32
Citations by year
2026: 34 · 2025: 71 · 2024: 76 · 2023: 78 · 2022: 72 · 2021: 96 · 2020: 97 · 2019: 70 · 2018: 67 · 2017: 76 · 2016: 67 · 2015: 83 · 2014: 78 · 2013: 89 · 2012: 81
FWCI
43.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • National Institutes of Health
  • University of California, San Francisco
  • National Institute of Neurological Disorders and Stroke (R01NS050284, R01 NS50284-03)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
tauopathy, prion-like propagation, fluid-phase endocytosis, Alzheimer's disease, frontotemporal dementia
MeSH terms
Animals, Animals, Newborn, Cell Line, Dextrans, Extracellular Space, Flow Cytometry, Fluorescent Antibody Technique, Humans, Kidney, Luminescent Proteins, Neurons, Stem Cells, Blotting, Western, tau Proteins, Protein Folding, Microscopy, Atomic Force, Coculture Techniques, Intracellular Space, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review